LATAM Meeting & Summit LACTRIMS 2025

Building the future in MS and NMOSD

We come together again with a shared purpose: to deepen our understanding, enhance management strategies, and work collectively toward innovative solutions that improve the lives of those affected by these diseases.

Over the course of this event, you will hear from esteemed experts who will present the latest advancements in research, diagnostics, and treatment approaches. You will also learn from the lived experiences of individuals with MS, reminding you of the importance of patient-centered care and interdisciplinary collaboration.

This symposium is more than just an exchange of knowledge; it is a call to action to foster connections, challenge current practices, and inspire progress. MS and NMOSD challenges us to innovate, and we are confident that, together, you can make meaningful strides in addressing these conditions.

The VI Charcot-LATAM Meeting and the II SUMMIT LACTRIMS Meeting will take place in Santiago de Chile, Chile, on May 9 - 10, 2025. The topic of the programme will be “Building the future in MS and NMOSD”.

Programme

Session I: MS diagnosis

9.00 - 9.15
Chair: Hans-Peter Hartung

9.15 - 9.35
2024 revision of the McDonald criteria: an overview Jorge Correale

9.35 - 9.55
When RIS can be diagnosed as MS? Christine Lebrun-Frenay (virtual)

9.55 - 10.15
Role of the optic nerve in the new diagnostic criteria. Letizia Leocani (virtual)

10.15 - 10.35
Application of the 2024/2017 Dx criteria in clinical practice. Agustín Pappolla

10.35 - 10.50
Q&A

10.50 - 11.20
Coffee Break

Session II: Laboratory and neuroimaging biomarkers in MS

11.20 - 11.40
Serum NfL as a biomarker in RIS patients. Hans-Peter Hartung

11.40 - 12.00
Kappa Free Light Chain Index as a diagnostic biomarker in MS. Carlos Navas

12.00 - 12.20
Cerebral vein sign (CVS) as a biomarker for MS diagnosis. Daniel Ontaneda

12.20 - 12.40
Paramagnetic rim lesions (PRL) and its role in MS diagnosis. Daniel Ontaneda

12.40 - 12.55
Q&A

Session III: MS treatment I

Session III: MS treatment II

Session IV: Patient-focused strategies

Session V: NMOSD and Mo

More information

Santiago de Chile
May 09, 2025 - May 10, 2025